Single-cell proteomics of postmortem human spinal motor neurons have revealed that retromer deficiency accompanies TDP-43 neuronal cytoplasmic aggregates (TDP-43+ NCI) [61], and that retromer-targeted pharmacological chaperones confer neuroprotection in ALS [62]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.